[Double blind test with hexoprenaline (Ipradol)-dosage-aerosol apparatus in bronchial asthma].
D000293:Adolescent; D000328:Adult; D000336:Aerosols; D000420:Albuterol / Q000494:pharmacology; D000605:Amino Alcohols / Q000008:administration & dosage* / Q000494:pharmacology; D001249:Asthma / Q000188:drug therapy* / Q000503:physiopathology; D001794:Blood Pressure / Q000187:drug effects; D001993:Bronchodilator Agents / Q000008:administration & dosage* / Q000494:pharmacology; D002986:Clinical Trials as Topic; D005260:Female; D006801:Humans; D008297:Male; D009921:Metaproterenol / Q000008:administration & dosage; D008875:Middle Aged; D010100:Oxygen; D010101:Oxygen Consumption / Q000187:drug effects; D010313:Partial Pressure; D010627:Phenethylamines / Q000008:administration & dosage / Q000494:pharmacology; D011674:Pulse / Q000187:drug effects; D014692:Ventilation-Perfusion Ratio / Q000187:drug effects; D014797:Vital Capacity / Q000187:drug effects
D000336:Aerosols; D000605:Amino Alcohols; D001993:Bronchodilator Agents; D010627:Phenethylamines; D009921:Metaproterenol; D000420:Albuterol; D010100:Oxygen
Doppeltblindversuch mit dem Hexoprenalin (Ipradol)-Dosier-Aerosolgerät bei Bronchialasthma